Subscribe To
novartis says drug candidate is successful in rare kidney disease trial
novartis said its experimental drug atrasentan was shown to have a positive effect on kidney function i...
October 30, 2023, 3:42 am
New and improved novartis
novartis recently completed the spin-off of Sandoz, which improved its growth and margin profile. The b...
October 29, 2023, 11:51 pm
2 green flags and 1 red flag for novartis stock
novartis just spun off Sandoz, its generic division. The company has a huge pipeline of upcoming drug c...
October 27, 2023, 5:05 am
novartis ag (nvs) q3 2023 earnings call transcript
novartis AG (NYSE:NVS ) Q3 2023 Earnings Call Transcript October 24, 2023 8:00 AM ET Company Participan...
October 24, 2023, 1:55 pm
novartis (nvs) tops q3 earnings, ups operating income view
novartis (NVS) beats on earnings in the third quarter and raises its annual guidance for core operating...
October 24, 2023, 10:32 am
novartis raises outlook after sandoz generics spinoff
novartis CEO Vas Narasimhan discusses third-quarter results with the company lifting its profit forecas...
October 24, 2023, 6:24 am
novartis begins new era with profit beat and guidance hike
The Swiss pharmaceutical company says its transition to a pure-play innovative medicines business is now complete following the spinoff of Sandoz, its...
October 24, 2023, 5:44 am
novartis lifts earnings guidance a third time this year on higher sales, profit
novartis lifts earnings guidance a third time this year on higher sales, profit Read Full Story The pos...
October 24, 2023, 5:33 am
novartis lifts 2023 earnings forecast for third time
novartis on Tuesday raised its full-year earnings forecast for the third time on strong drug sales, aft...
October 24, 2023, 1:12 am
novartis (nvs) to report q3 earnings: what's in the offing?
Investor focus is likely to be on the top and bottom-line numbers, and updates on guidance post-Sandoz spin-off when ...
October 20, 2023, 12:02 pm
novartis (nvs) suffers a larger drop than the general market: key insights
The latest trading day saw novartis (NVS) settling at $97.87, representing a -1.55% change from its pre...
October 12, 2023, 7:32 pm
Eli lilly, mckesson, novartis flash promising chart action
Although healthcare stocks lag other sectors, large-cap leaders such as Eli Lilly & Co. NYSE: LLY, McKesson Corp. NYSE: MCK and ...
October 9, 2023, 7:19 am
novartis leads funding round for uk alzheimer's specialist
UK-based biotech firm AstronauTx has secured £48 million ($61 million) in a significant Series A funding round, marking a step towards developing tre...
October 9, 2023, 2:16 am
novartis (nvs) ascends but remains behind market: some facts to note
novartis (NVS) closed at $97.14 in the latest trading session, marking a +1.03% move from the prior day...
October 6, 2023, 7:32 pm
novartis: better margin visibility ex-sandoz
Ex-Sandoz, novartis confirmed its yearly guidance and capital allocation priority (DPS growth and buyba...
October 6, 2023, 12:48 am
novartis to present new oncology data at esmo 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer
Basel, October 5, 2023 — novartis will present new data from 29 ...
October 5, 2023, 1:15 am
novartis (nvs) spins off sandoz, reiterates annual outlook
novartis (NVS) separates Sandoz into an independent company. The company reaffirms the previously provi...
October 4, 2023, 1:31 pm
Sdzny stock: 7 things to know as novartis spinoff sandoz starts trading today
Sandoz (OTCMKT: SDZNY ) stock is a hot topic among traders on Wednesday as the company starts trading after a spinoff. Let's get into everything inves...
October 4, 2023, 11:33 am
novartis spin-off completed as sandoz makes subdued start on swiss bourse
Swiss drugs giant novartis AG has completed the spin-off of its generics business Sandoz, which made an...
October 4, 2023, 7:13 am
novartis unit sandoz set to start trading after completing spinoff
novartis has completed the planned spin-off of its generics and biosimilars business, Sandoz, which wil...
October 4, 2023, 1:51 am